The U.S. Food and Drug Administration (FDA) has approved the topical foam Zoryve (roflumilast) to treat an inflammatory skin condition known as seborrheic dermatitis, commonly called scalp eczema ...
Medically reviewed by Leah Ansell, MDDry patches on your face can be caused by skin conditions such as psoriasis, eczema, and ...